Pinnacle Foods Inc. announced the appointment of Michael S. Levitt to the newly created role of Senior Vice President Corporate Development, effective October 31.
Levitt will report to Craig Steeneck, Executive Vice President and Chief Financial Officer, and will partner with Steeneck and Pinnacle CEO Mark Clouse in developing and assessing M&A opportunities that support the Company’s strategic plan.
Levitt, 47, co-founded LG Capital Management, LP, a private investment fund that invested in publicly traded securities, and served as its Portfolio Manager since the fund’s 2011 inception. Prior to LG Capital Management, he worked as a Research Analyst at Chesapeake Partners and as Director in the M&A and Corporate Advisory Group at Deutsche Bank Securities, Inc. Earlier in his career, Levitt was a practicing attorney specializing in M&A work at Paul, Weiss, Rifkind, Wharton & Garrison.
Levitt holds a Juris Doctor with Honors from George Washington University and a Bachelor of Arts in Economics from the University of Pennsylvania.
Commenting on the appointment, Steeneck stated, “We are excited to welcome Michael to Pinnacle in this important leadership role. His well-rounded experiences in law, banking and investment management and research will be an asset to Pinnacle and position him as a strong partner to the executive team in implementing the Company’s strategic business development plan.”
Source: Street Insider
The company expects to eliminate 1.2 billion tons carbon dioxide equivalent of methane emissions by the end of the decade. The company says that it already reduced its methane emissions by around 14% between 2018 and 2020.
The “first-of-its-kind” pilot project will develop and demonstrate an affordable modular bioprocessing system to produce biodegradable bioplastics from food waste diverted from landfills. The three-year grant will test the scalability and feasibility of the conversion on a national and global scale.
Arkeon is allying with specialty mineral giant ICL to support the scaling of its fermentation bioprocess that converts CO2 into the 20 proteinogenic essential amino acids needed in human nutrition. The process, hailed as carbon negative, is based on the use of archaea, a group of microorganisms that naturally feeds off the greenhouse gas.